LIANG Shu-jie, GENG Su-xia, LAI Pei-long, DU Xin. Research Advances in CAR-T Cell Therapy for Hematologic Tumors in 2022[J]. Journal of Evidence-Based Medicine, 2022, 22(6): 340-349. DOI: 10.12019/j.issn.1671-5144.2022.06.006
|
Citation:
|
LIANG Shu-jie, GENG Su-xia, LAI Pei-long, DU Xin. Research Advances in CAR-T Cell Therapy for Hematologic Tumors in 2022[J]. Journal of Evidence-Based Medicine, 2022, 22(6): 340-349. DOI: 10.12019/j.issn.1671-5144.2022.06.006
|
LIANG Shu-jie, GENG Su-xia, LAI Pei-long, DU Xin. Research Advances in CAR-T Cell Therapy for Hematologic Tumors in 2022[J]. Journal of Evidence-Based Medicine, 2022, 22(6): 340-349. DOI: 10.12019/j.issn.1671-5144.2022.06.006
|
Citation:
|
LIANG Shu-jie, GENG Su-xia, LAI Pei-long, DU Xin. Research Advances in CAR-T Cell Therapy for Hematologic Tumors in 2022[J]. Journal of Evidence-Based Medicine, 2022, 22(6): 340-349. DOI: 10.12019/j.issn.1671-5144.2022.06.006
|
DownLoad: